Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-20.33	33.69	42.29
Graham Fair Price	19.80	20.70	17.27
PEG	-88.98	0.58	5.26
Price/Book	-22.23	5.00	6.43
Price/Cash Flow	20.95	48.46	40.07
Prices/Earnings	-31.28	15.38	22.38
Price/Sales	-18.63	4.28	5.26
Price/FCF	20.95	48.46	40.07
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	25.54	0.18	0.15
Operating Margin	15.06	0.11	0.10
ROA	26.25	0.02	0.02
ROE	0.07	0.08	13.17
ROIC	0.03	0.04	17.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	0.03	-57.07
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.14	0.24	74.61
EPS QOQ	0.04	0.27	523.47
FCF QOQ	0.22	-0.28	22.69
Revenue QOQ	-0.05	0.08	39.04
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-99.99
Days Sales Outstanding (DSO)	89.57	85.83	-4.18
Inventory Turnover	18912.70	194673000.00	1029224.21
Debt/Capitalization	0.62	0.59	-4.92
Quick Ratio	2.00	2.32	16.09
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.60	15.31	12.61
Cash	8.70	10.21	17.30
Capex	-0.16	-0.11	28.75
Free Cash Flow	2.18	1.58	-27.59
Revenue	16.62	17.89	7.62
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.10	2.39	13.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.55	5.37	-17.97
Naive Interpretation	Member

06 - Financial Health · Bad

Rating